Lauterbach Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
Lauterbach Financial Advisors's PFE Position: Q2 2026 in Review
Lauterbach Financial Advisors increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $13.9K and bringing the position to 47,299 shares worth $1.14M. The position accounts for 0.49% of the portfolio, ranked #29.
Lauterbach Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.31M in Q1 2026. 1,328 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Lauterbach Financial Advisors held 47,299 shares of Pfizer worth $1.14M as of Q2 2026.
- Lauterbach Financial Advisors bought 531 Pfizer shares in Q2 2026, an estimated $13.9K.
- Pfizer made up 0.49% of Lauterbach Financial Advisors's portfolio in Q2 2026, its #29 holding.
- Lauterbach Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Lauterbach Financial Advisors's Pfizer position peaked at $1.31M in Q1 2026.
- 1,328 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Lauterbach Financial Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.